Chronic Kidney Disease
Chronic Kidney Disease
06/21/2021
The US Food and Drug Administration has approved a new generic option for the control of serum phosphorus levels in patients with chronic kidney disease who are undergoing dialysis.
06/21/2021
FDA
FDA
02/06/2018
The US Food and Drug Administration has expanded the indication for a drug for chronic kidney disease to now include certain patients without chronic kidney disease.
02/06/2018
Cardiometabolic Risk
Cardiometabolic Risk
04/11/2016
The FDA has required labeling changes regarding recommendation of metformin treatment in patients with reduced kidney function.
04/11/2016